A Study to Evaluate the Effects of a Supplement on the Side Effects Associated With Stimulant Medications

Recruiting now · Not applicable · Has a placebo group

Conditions studied: ADHD, Sleep Disturbance, Brain Fog

In brief

This is a hybrid, two-arm, triple-blind, placebo-controlled, randomized clinical trial evaluating the efficacy of the Stasis supplement on reducing oxidative stress, cortisol levels, and side effects associated with stimulant medications used for ADHD over a three-month period in adults.

Key facts

Study ID

NCT07380412

Run by

Outliers, Inc.

People needed

90

Starts

2025-08-12

Expected to finish

2026-03-01

Last updated by the study team

2026-02-02

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Aged 18-55 years
• Currently prescribed stimulant medication for ADHD
• Experiencing: sleep difficulty, irritability, anxiety, brain fog
• Stable medication dose ≥3 months
• Healthy with no uncontrolled chronic conditions
• Stable on supplements ≥3 months if applicable
• US resident
• Willing to maintain current habits

You may not qualify if…

• Chronic conditions (e.g. cancer, mental illness)
• Use of psychiatric medications besides stimulants
• Pregnancy, breastfeeding, thyroid, liver, kidney conditions
• Recent smokers or heavy alcohol use
• Night shift workers
• Participation in other clinical trials
• Allergies to product ingredients

Where it is running

• Citruslabs — Las Vegas, Nevada, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.